Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

79.00
EUR
+0.50
(+0.64%)
-3.46EPS
4.36BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q4 FY2025 · Presentation

Dianthus_Corp Presentation_JPMorgan_2026.01.12 · 29 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents